These data suggest that IL-1β has dual functions in tumour development, that is, antitumour immunity through tumour antigen-specific CTL-mediated effects and pro-tumour effects in a chronic inflammatory environment in an antigen-independent manner. Here, IL1B is linked to neoplasm.